Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Dec 11, 2025
Curtiss-Wright (CW) Stock Analysis: Recent Price Movements and Market Outlook

Curtiss-Wright (CW) Stock Analysis: Recent Price Movements and Market Outlook

Key Takeaways

  • Curtiss-Wright (CW) has experienced a modest pullback in recent weeks amid broader market adjustments, yet maintains strong year-to-date gains driven by robust operational performance.
  • The company's third-quarter results exceeded expectations, with sales growth and improved margins supporting positive investor sentiment.
  • A significant expansion of the share repurchase program underscores management's confidence in long-term value.
  • Analyst upgrades and adjustments reflect optimism about CW's position in defense and industrial sectors.
  • Dividend declarations continue to provide steady returns for income-focused investors.
  • Market volatility has been influenced by sector dynamics, but CW's fundamentals remain solid.

Current Market Snapshot

Curtiss-Wright Corporation (CW) has demonstrated resilience in recent trading sessions, navigating a period of moderate volatility within the aerospace and defense sector. The stock has shown upward momentum over the latest market cycle, supported by strong demand in commercial and military applications. With a market capitalization in the mid-tier range and a price-to-earnings ratio indicating growth potential, CW appeals to investors seeking exposure to industrial diversification. Recent weeks have seen the stock consolidate after a multi-month advance, reflecting broader economic uncertainties, yet underlying fundamentals like consistent revenue streams and efficient capital returns position it favorably. This snapshot highlights CW's ability to maintain stability amid shifting market sentiments, making it a noteworthy option in stock analysis for those monitoring price movement and market outlook.

AI Trading Bot Spotlight: CW / SOXS - AI Trading Double Agent, 5min

The CW / SOXS - AI Trading Double Agent, 5min is an AI-driven swing trading bot developed by Tickeron, focusing on a hedged strategy between Curtiss-Wright (CW) and the Direxion Daily Semiconductor Bear 3X Shares (SOXS). It utilizes 5-minute chart patterns for entry signals via financial learning models and machine learning, while confirming exits on daily timeframes to capture larger market moves. The bot emphasizes long positions in CW with SOXS as a bearish hedge, suitable for medium-volatility environments and growing markets. Historical performance over the past year shows an annualized return of +106%, with a balanced risk-reward profile and automated risk controls limiting open positions to 10. This approach reduces emotional trading decisions, making it accessible for beginners. Investors interested in AI-enhanced strategies may explore this bot to assess its potential in their portfolios.

Recent Developments Driving CW Price Action

In the past 30 days, Curtiss-Wright Corporation (CW) has been influenced by a series of corporate announcements and analyst activities that have contributed to its stock price dynamics. On November 20, 2025, the company expanded its share repurchase program by an additional $416 million, bringing the total authorization for 2025 to $550 million. This move, aimed at enhancing shareholder value, was positively received and helped stabilize sentiment amid a broader market pullback, as it signaled strong confidence in the company's financial health and future prospects. The stock experienced a roughly 7% decline over the recent month, partly attributed to profit-taking after a robust year-to-date performance exceeding 50%, but the buyback provided a supportive floor.

Complementing this, Curtiss-Wright declared a quarterly dividend of $0.24 per share on November 20, 2025, payable on December 5, 2025, to shareholders of record as of November 28, 2025. This continuation of dividend payments, yielding approximately 0.18%, reinforced the company's commitment to returning capital, appealing to income-oriented investors and contributing to modest upward pressure on the stock in subsequent sessions.

Analyst actions have also played a role in shaping market sentiment. On November 10, 2025, Morgan Stanley maintained its Overweight rating on CW and raised its price target from $565 to $645, citing the company's strong third-quarter results and growth in defense and nuclear sectors. This upgrade bolstered optimism, leading to a brief uptick in trading volume. Conversely, Argus Research adjusted its price target multiple times: lowering it to $597 recently, after previous revisions to $606 and $615, while maintaining a Hold rating in some instances. These changes reflect a mixed but generally positive consensus, with an average price target around $608, influencing intraday volatility as investors weighed valuation concerns against operational strengths.

Although slightly outside the strict 30-day window, the third-quarter earnings release on November 5, 2025, continued to impact sentiment into mid-November. Curtiss-Wright reported sales of $869 million, up 9% year-over-year, with operating income of $166 million and a margin of 19.1%. Earnings per share reached $3.40, surpassing estimates of $3.29, driven by higher demand in aerospace, defense, and power segments. The company also raised its full-year 2025 guidance, projecting sales growth of 7-9% and adjusted EPS of $12.15-$12.35. This outperformance fueled initial gains but later contributed to the pullback as the market digested the results amid macroeconomic pressures, including interest rate uncertainties and sector rotations away from industrials.

Insider transactions added nuance to price action, with sales by executives such as John Watts on November 25, Lynn Bamford on November 17, and K. Farkas on November 13, totaling shares worth several million dollars. While routine, these sells coincided with the stock's consolidation phase, potentially amplifying downward momentum in low-volume sessions.

Industry factors have indirectly affected CW, with ongoing strength in global defense spending supporting the stock's resilience. However, broader economic indicators, such as easing volatility in recent days as markets anticipate potential rate cuts, have tempered aggressive buying. No major acquisitions, partnerships, or regulatory changes were reported in the period, keeping focus on internal catalysts. Overall, these developments have driven CW's price to hover around $550-$555, reflecting a balance between positive fundamentals and short-term market adjustments, with trading volume averaging around 250,000 shares.

Forward-Looking Factors to Watch

Traders and investors in Curtiss-Wright (CW) should monitor several known upcoming events and catalysts that could influence the stock's performance. The company's fourth-quarter and full-year 2025 earnings results are expected in early February 2026, based on historical reporting patterns, where management will provide updates on sales, EPS, and 2026 guidance. Consensus estimates project EPS of approximately $3.69 for the quarter, with full-year figures aligning to the raised outlook of $12.15-$12.35.

Participation in industry conferences may offer insights into operational progress. Curtiss-Wright is scheduled for the Weapons and Tactics Conference on January 14, 2026, and the WEST conference on February 10, 2026, focusing on naval and defense technologies. Additionally, the 2026 RAPID Conference and Vendor Exhibit from May 17-20, 2026, will highlight advancements in power generation, potentially revealing product updates or partnerships in the nuclear and energy sectors.

Regulatory developments in defense and aerospace, including U.S. government budget approvals for fiscal 2026, could impact contract flows, as CW derives significant revenue from military programs. Macroeconomic indicators, such as Federal Reserve interest rate decisions and inflation reports, will continue to affect sector sentiment, given CW's exposure to capital-intensive industries. Consensus expectations emphasize sustained demand in commercial aerospace recovery and nuclear power expansion, without introducing new speculation.

Disclaimers and Limitation

Related Ticker: CW

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CW's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CW turned positive on September 15, 2026. Looking at past instances where CW's MACD turned positive, the stock continued to rise in 40 of 49 cases over the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CW's RSI Oscillator exited the oversold zone, 8 of 12 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 49 cases where CW's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.

Following a +0.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where CW advanced for three days, in 259 of 381 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

CW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CW as a result. In 51 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 52%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.

The Aroon Indicator for CW entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 28 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.

The Tickeron SMR rating for this company is 47 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. CW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.097) is normal, around the industry mean (6.305). P/E Ratio (36.639) is within average values for comparable stocks, (58.116). Projected Growth (PEG Ratio) (1.650) is also within normal values, averaging (2.564). Dividend Yield (0.002) settles around the average of (0.009) among similar stocks. P/S Ratio (5.811) is also within normal values, averaging (18.330).

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 38.94B. The market cap for tickers in the group ranges from 4.49 to 1.92T. SPCX holds the highest valuation in this group at 1.92T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -3%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -12%. SPCX experienced the highest price growth at 18%, while PUSA experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was 41% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 70
Price Growth Rating: 62
SMR Rating: 77
Profit Risk Rating: 76
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
CW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of high tech, critical function products, systems and services to the commercial, industrial, defense and power markets

Industry AerospaceDefense

Industry
Aerospace And Defense
Address
130 Harbour Place Drive
Phone
+1 704 869-4600
Employees
9100
Web
https://www.curtisswright.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.